CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A

CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A

C‐terminal binding protein‐2 (CtBP2), as a transcriptional co‐repressor, has been shown to mediate the repression of p16 INK4A , a tumor suppressor gene product, in primary human cells. Here we aimed to investigate how the correlation between CtBP2 and p16 INK4A influenced the development of esophag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2013-06, Vol.114 (6), p.1343-1354
Hauptverfasser: Guan, Chengqi, Shi, Hui, Wang, Huijie, Zhang, Jianguo, Ni, Wenkai, Chen, Buyou, Hou, Sicong, Yang, Xiaojing, Shen, Aiguo, Ni, Runzhou
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1354
container_issue 6
container_start_page 1343
container_title Journal of cellular biochemistry
container_volume 114
creator Guan, Chengqi
Shi, Hui
Wang, Huijie
Zhang, Jianguo
Ni, Wenkai
Chen, Buyou
Hou, Sicong
Yang, Xiaojing
Shen, Aiguo
Ni, Runzhou
description C‐terminal binding protein‐2 (CtBP2), as a transcriptional co‐repressor, has been shown to mediate the repression of p16 INK4A , a tumor suppressor gene product, in primary human cells. Here we aimed to investigate how the correlation between CtBP2 and p16 INK4A influenced the development of esophageal squamous cell carcinoma (ESCC). Immunohistochemistry of ESCC tissue sections indicated that the CtBP2 and p16 INK4A expressions were inversely correlated to each other with a linear regression coefficient of −0.747 ( P  
doi_str_mv 10.1002/jcb.24475
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jcb_24475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1002_jcb_24475</sourcerecordid><originalsourceid>FETCH-LOGICAL-c745-b628fe6a71a6ad16ba607611f81e48e0c0846def2d658fce6213dfa4853bcc713</originalsourceid><addsrcrecordid>eNot0DtPwzAUBWALgUQpDPwDrwwpfsVOx1LxqKiAoXt041y3qZw4tROk_ntaYDpnOWf4CLnnbMYZE497W82EUia_IBPO5iZTWqlLMmFGskxILq7JTUp7xth8LsWEHJbD05egNnRDbKpxwESHQFvwzbaDbqA1fqMPfYunHhzdjS10FFPod7BF8DQdRmjDmKhF76mFaJsutECrI424HT0MTejOy55ruvp4V4tbcuXAJ7z7zynZvDxvlm_Z-vN1tVysM2tUnlVaFA41GA4aaq4r0Mxozl3BURXILCuUrtGJWueFs6gFl7UDVeSystZwOSUPf7c2hpQiurKPTQvxWHJWnqnKE1X5SyV_AMToXVE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Guan, Chengqi ; Shi, Hui ; Wang, Huijie ; Zhang, Jianguo ; Ni, Wenkai ; Chen, Buyou ; Hou, Sicong ; Yang, Xiaojing ; Shen, Aiguo ; Ni, Runzhou</creator><creatorcontrib>Guan, Chengqi ; Shi, Hui ; Wang, Huijie ; Zhang, Jianguo ; Ni, Wenkai ; Chen, Buyou ; Hou, Sicong ; Yang, Xiaojing ; Shen, Aiguo ; Ni, Runzhou</creatorcontrib><description>C‐terminal binding protein‐2 (CtBP2), as a transcriptional co‐repressor, has been shown to mediate the repression of p16 INK4A , a tumor suppressor gene product, in primary human cells. Here we aimed to investigate how the correlation between CtBP2 and p16 INK4A influenced the development of esophageal squamous cell carcinoma (ESCC). Immunohistochemistry of ESCC tissue sections indicated that the CtBP2 and p16 INK4A expressions were inversely correlated to each other with a linear regression coefficient of −0.747 ( P  &lt; 0.05), and Western blot analysis revealed that CtBP2 was higher expressed in tumorous tissues than in adjacent non‐tumorous tissues. Either CtBP2 or p16 INK4A expression was significantly related to histological differentiation ( P  = 0.016 or 0.001) and to the expression of Ki‐67, a proliferating marker ( P  = 0.006 or 0.02), and patients with higher CtBP2 and lower p16 INK4A expressions had shorter overall survival. We also observed that CtBP2 modulated the cell proliferation and cell cycle in ECA109 cells, an ESCC cell line, by inhibiting p16 INK4A . Overexpression or knockdown of CtBP2 in ECA109 cells was found to inhibit or activate the mRNA or protein expression of p16 INK4A , which in turn altered the cell proliferation and cell cycle in ECA109 cells, as measured by flow cytometry and cell count assay. Additionally, after ECA109 cells silenced for CtBP2 were treated with cisplatin (an anti‐ESCC agent), the p16 INK4A expression was up‐regulated, and the cell apoptosis was promoted, thus confirming the repression of p16 INK4A by CtBP2. Collectively, all results suggested that CtBP2 might contribute to the progression of ESCC through a negative transcriptional regulation of p16 INK4A . J. Cell. Biochem. 114: 1343–1354, 2013. © 2013 Wiley Periodicals, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.24475</identifier><language>eng</language><ispartof>Journal of cellular biochemistry, 2013-06, Vol.114 (6), p.1343-1354</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c745-b628fe6a71a6ad16ba607611f81e48e0c0846def2d658fce6213dfa4853bcc713</citedby><cites>FETCH-LOGICAL-c745-b628fe6a71a6ad16ba607611f81e48e0c0846def2d658fce6213dfa4853bcc713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Guan, Chengqi</creatorcontrib><creatorcontrib>Shi, Hui</creatorcontrib><creatorcontrib>Wang, Huijie</creatorcontrib><creatorcontrib>Zhang, Jianguo</creatorcontrib><creatorcontrib>Ni, Wenkai</creatorcontrib><creatorcontrib>Chen, Buyou</creatorcontrib><creatorcontrib>Hou, Sicong</creatorcontrib><creatorcontrib>Yang, Xiaojing</creatorcontrib><creatorcontrib>Shen, Aiguo</creatorcontrib><creatorcontrib>Ni, Runzhou</creatorcontrib><title>CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A</title><title>Journal of cellular biochemistry</title><description>C‐terminal binding protein‐2 (CtBP2), as a transcriptional co‐repressor, has been shown to mediate the repression of p16 INK4A , a tumor suppressor gene product, in primary human cells. Here we aimed to investigate how the correlation between CtBP2 and p16 INK4A influenced the development of esophageal squamous cell carcinoma (ESCC). Immunohistochemistry of ESCC tissue sections indicated that the CtBP2 and p16 INK4A expressions were inversely correlated to each other with a linear regression coefficient of −0.747 ( P  &lt; 0.05), and Western blot analysis revealed that CtBP2 was higher expressed in tumorous tissues than in adjacent non‐tumorous tissues. Either CtBP2 or p16 INK4A expression was significantly related to histological differentiation ( P  = 0.016 or 0.001) and to the expression of Ki‐67, a proliferating marker ( P  = 0.006 or 0.02), and patients with higher CtBP2 and lower p16 INK4A expressions had shorter overall survival. We also observed that CtBP2 modulated the cell proliferation and cell cycle in ECA109 cells, an ESCC cell line, by inhibiting p16 INK4A . Overexpression or knockdown of CtBP2 in ECA109 cells was found to inhibit or activate the mRNA or protein expression of p16 INK4A , which in turn altered the cell proliferation and cell cycle in ECA109 cells, as measured by flow cytometry and cell count assay. Additionally, after ECA109 cells silenced for CtBP2 were treated with cisplatin (an anti‐ESCC agent), the p16 INK4A expression was up‐regulated, and the cell apoptosis was promoted, thus confirming the repression of p16 INK4A by CtBP2. Collectively, all results suggested that CtBP2 might contribute to the progression of ESCC through a negative transcriptional regulation of p16 INK4A . J. Cell. Biochem. 114: 1343–1354, 2013. © 2013 Wiley Periodicals, Inc.</description><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNot0DtPwzAUBWALgUQpDPwDrwwpfsVOx1LxqKiAoXt041y3qZw4tROk_ntaYDpnOWf4CLnnbMYZE497W82EUia_IBPO5iZTWqlLMmFGskxILq7JTUp7xth8LsWEHJbD05egNnRDbKpxwESHQFvwzbaDbqA1fqMPfYunHhzdjS10FFPod7BF8DQdRmjDmKhF76mFaJsutECrI424HT0MTejOy55ruvp4V4tbcuXAJ7z7zynZvDxvlm_Z-vN1tVysM2tUnlVaFA41GA4aaq4r0Mxozl3BURXILCuUrtGJWueFs6gFl7UDVeSystZwOSUPf7c2hpQiurKPTQvxWHJWnqnKE1X5SyV_AMToXVE</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Guan, Chengqi</creator><creator>Shi, Hui</creator><creator>Wang, Huijie</creator><creator>Zhang, Jianguo</creator><creator>Ni, Wenkai</creator><creator>Chen, Buyou</creator><creator>Hou, Sicong</creator><creator>Yang, Xiaojing</creator><creator>Shen, Aiguo</creator><creator>Ni, Runzhou</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201306</creationdate><title>CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A</title><author>Guan, Chengqi ; Shi, Hui ; Wang, Huijie ; Zhang, Jianguo ; Ni, Wenkai ; Chen, Buyou ; Hou, Sicong ; Yang, Xiaojing ; Shen, Aiguo ; Ni, Runzhou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c745-b628fe6a71a6ad16ba607611f81e48e0c0846def2d658fce6213dfa4853bcc713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guan, Chengqi</creatorcontrib><creatorcontrib>Shi, Hui</creatorcontrib><creatorcontrib>Wang, Huijie</creatorcontrib><creatorcontrib>Zhang, Jianguo</creatorcontrib><creatorcontrib>Ni, Wenkai</creatorcontrib><creatorcontrib>Chen, Buyou</creatorcontrib><creatorcontrib>Hou, Sicong</creatorcontrib><creatorcontrib>Yang, Xiaojing</creatorcontrib><creatorcontrib>Shen, Aiguo</creatorcontrib><creatorcontrib>Ni, Runzhou</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guan, Chengqi</au><au>Shi, Hui</au><au>Wang, Huijie</au><au>Zhang, Jianguo</au><au>Ni, Wenkai</au><au>Chen, Buyou</au><au>Hou, Sicong</au><au>Yang, Xiaojing</au><au>Shen, Aiguo</au><au>Ni, Runzhou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A</atitle><jtitle>Journal of cellular biochemistry</jtitle><date>2013-06</date><risdate>2013</risdate><volume>114</volume><issue>6</issue><spage>1343</spage><epage>1354</epage><pages>1343-1354</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>C‐terminal binding protein‐2 (CtBP2), as a transcriptional co‐repressor, has been shown to mediate the repression of p16 INK4A , a tumor suppressor gene product, in primary human cells. Here we aimed to investigate how the correlation between CtBP2 and p16 INK4A influenced the development of esophageal squamous cell carcinoma (ESCC). Immunohistochemistry of ESCC tissue sections indicated that the CtBP2 and p16 INK4A expressions were inversely correlated to each other with a linear regression coefficient of −0.747 ( P  &lt; 0.05), and Western blot analysis revealed that CtBP2 was higher expressed in tumorous tissues than in adjacent non‐tumorous tissues. Either CtBP2 or p16 INK4A expression was significantly related to histological differentiation ( P  = 0.016 or 0.001) and to the expression of Ki‐67, a proliferating marker ( P  = 0.006 or 0.02), and patients with higher CtBP2 and lower p16 INK4A expressions had shorter overall survival. We also observed that CtBP2 modulated the cell proliferation and cell cycle in ECA109 cells, an ESCC cell line, by inhibiting p16 INK4A . Overexpression or knockdown of CtBP2 in ECA109 cells was found to inhibit or activate the mRNA or protein expression of p16 INK4A , which in turn altered the cell proliferation and cell cycle in ECA109 cells, as measured by flow cytometry and cell count assay. Additionally, after ECA109 cells silenced for CtBP2 were treated with cisplatin (an anti‐ESCC agent), the p16 INK4A expression was up‐regulated, and the cell apoptosis was promoted, thus confirming the repression of p16 INK4A by CtBP2. Collectively, all results suggested that CtBP2 might contribute to the progression of ESCC through a negative transcriptional regulation of p16 INK4A . J. Cell. Biochem. 114: 1343–1354, 2013. © 2013 Wiley Periodicals, Inc.</abstract><doi>10.1002/jcb.24475</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2013-06, Vol.114 (6), p.1343-1354
issn 0730-2312
1097-4644
language eng
recordid cdi_crossref_primary_10_1002_jcb_24475
source Wiley Online Library Journals Frontfile Complete
title CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A43%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CtBP2%20contributes%20to%20malignant%20development%20of%20human%20esophageal%20squamous%20cell%20carcinoma%20by%20regulation%20of%20p16%20INK4A&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Guan,%20Chengqi&rft.date=2013-06&rft.volume=114&rft.issue=6&rft.spage=1343&rft.epage=1354&rft.pages=1343-1354&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.24475&rft_dat=%3Ccrossref%3E10_1002_jcb_24475%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true